PICCIOTTO, Maria
 Distribuzione geografica
Continente #
NA - Nord America 1.045
EU - Europa 979
AS - Asia 162
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.188
Nazione #
US - Stati Uniti d'America 1.041
SE - Svezia 267
IE - Irlanda 227
IT - Italia 185
CN - Cina 146
UA - Ucraina 73
PL - Polonia 55
DE - Germania 49
FI - Finlandia 34
GB - Regno Unito 34
FR - Francia 32
BE - Belgio 17
IN - India 9
CA - Canada 4
RU - Federazione Russa 4
JP - Giappone 3
VN - Vietnam 2
A2 - ???statistics.table.value.countryCode.A2??? 1
EU - Europa 1
IR - Iran 1
NO - Norvegia 1
RO - Romania 1
SG - Singapore 1
Totale 2.188
Città #
Dublin 227
Chandler 212
Jacksonville 151
Nyköping 130
New York 70
Beijing 60
Ann Arbor 53
Warsaw 52
Ashburn 45
Dearborn 43
Messina 37
Princeton 37
Cambridge 35
Des Moines 33
Medford 31
Boardman 24
Brussels 17
Woodbridge 15
Wilmington 13
Hebei 12
Jinan 12
Nanjing 12
Shenyang 11
San Mateo 10
Lancaster 9
Leawood 8
Taizhou 7
Houston 6
Ningbo 6
Seattle 6
Los Angeles 5
Augusta 4
Tianjin 4
Auburn Hills 3
Carbonia 3
Guangzhou 3
Pune 3
Radomsko 3
Rome 3
Toronto 3
Changsha 2
Clearwater 2
Dong Ket 2
Falls Church 2
Genova 2
Grammichele 2
Hefei 2
Melito Irpino 2
Monmouth Junction 2
Sassari 2
Taiyuan 2
Torino 2
Villar Perosa 2
Zhengzhou 2
Ardabil 1
Bangalore 1
Beinasco 1
Bologna 1
Brescia 1
Calderara Di Reno 1
Cardano 1
Castell'arquato 1
Chicago 1
Concorezzo 1
Dallas 1
Fort Washington 1
Fuzhou 1
Haikou 1
Hangzhou 1
Hyderabad 1
Jiaxing 1
Kemerovo 1
Kumamoto 1
Kunming 1
Lanzhou 1
Lendinara 1
Marnate 1
Milan 1
Milazzo 1
Mola Di Bari 1
Monza 1
Mumbai 1
Nanchang 1
Novokuznetsk 1
Parabita 1
Parma 1
Quartu Sant'elena 1
Rivarolo Canavese 1
Rivoli 1
Romano di Lombardia 1
San Giorgio A Cremano 1
San Giuliano Milanese 1
Sant'antimo 1
Sant'oreste 1
Scicli 1
Seano 1
Senigallia 1
Sezze 1
Siena 1
Tappahannock 1
Totale 1.492
Nome #
Linfoscintigrafia ascellare preoperatoria nel cancro della mammella. 238
Prognostic value of methlylenetetrahydrofolate reductase (MTHFR), thymidylate synthase (TS) promoter, and p53 codon 72 variants and survival in advanced non-small cell lung cancer (NSCLC). 116
Trattamento endoscopico scleroterapico nelle neoplasie sanguinanti del tratto digestivo. 74
COMPARISON OF GASTRIC BRUSH CYTOLOGY AND BIOPSY IN DETECTION OF INFECTION BY HELICOBACTER-PYLORI 71
Third generation EGFR TKIs in EGFR-mutated NSCLC: Where are we now and where are we going 71
Trattamento palliativo dei tumori del retto-sigma mediante elettrocoagulazione endoscopica.” 68
Heterogeneous responses to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in patients with uncommon EGFR mutations: New insights and future perspectives in this complex clinical scenario 68
“Significato diagnostico dei markers tumorali nel succo gastrico e nel siero di pazienti affetti da neoplasia gastrica.” 67
INCIDENZA DELL'ONCOTIPO POLMONARE NELLO STESSO TERRITORIO IN TRIENNI DIFFERENTI- 1983/84/85 E 1993/94/95. Eur. Jour. of Oncology Vol. 2, n° 4, 1997. 66
AMIFOSTINE IN CONJUCTION WITH H.D. VP16 AND G-CSF ENABLE PBSC COLLECTION IN MULTIPLE MYELOMA PATIENTS WHO FAILED CTX INDUCED MOBILIZATION 66
Safety of Capecitabine plus Bevacizumab in heavily treated patients with metastatic colorectal cancer (MCRC) 66
Gefitinib versus Erlotinib treatment in Non Small Cell Lung Cancer (NSCLC): comparison of two clinical experiences. 65
A modified weekly docetaxel schedule as first-line chemotherapy in elderly metastatic breast cancer: A safety study 64
Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non small cell lung cancer. 64
Emerging role of Radium-223 in the growing therapeutic armamentarium of metastatic castration-resistant prostate cancer 64
HELICOBACTER-PYLORI IN GASTRODUODENAL DISEASES - RAPID IDENTIFICATION BY ENDOSCOPIC BRUSH CYTOLOGY 61
Epidermal growth factor receptor (EGFR) G719C mutation as new determinant of long term survival and response in patients with non small cell lung cancer treated with erlotinib: 60
Endobronchial electrocautery for the dehydration of lung cancer. 56
Vinorelbina orale (OV) come trattamento chemioterapico di prima linea nel carcinoma mammario ormonorefrattario (HRPC) dell'anziano. 54
ANCHE IN VIVO IL PAMIDRONATO E' UN INDUTTORE DELLA APOPTOSI NELLE PLASMACELLULE MIELOMATOSE 54
First Line Chemotherapy with Oral Vinorelbine (oV) in Elderly Hormone-Refractory Prostate Cancer (HRPC) Patients (pts 53
Incidenza dell’oncotipo polmonare nello stesso territorio in trienni differenti 1983/84/85 e 1993/94/95. 52
Terapia con Pamidronato disodico e induzione della apoptosi nelle plasmacellule mielomatose. 51
Epidermal growth factor receptor (EGFR) G719C mutation as new determinant of long term survival and response in patients with non small cell lung cancer treated with erlotinib: a case report. 51
Oral vinorelbine as first-line chemoptherapy in elderly patients with hormone-refractory prostate cancer. 50
Fine needle aspiration to improve the diagnosis in lung cancer. 50
Role of Androgen Receptor (AR), Ki 67 and E-cadherin as prognostic markers in Triple Negative Breast Cancer (TNBC) 47
Emerging targeted therapies for castration-resistant prostate cancer 45
Ruolo della fibrobroncoscopia nella diagnosi dei tumori polmonari: revisione di 10 anni di casistica. 43
Somministrazione Locale di VP-16 attraverso il fibrobroncoscopio nelle neoplasie polmonari inoperabili a sviluppo endobronchiale. 43
Palliative treatment of rectosigmoid tumors by endoscopic electrocoagulation 41
Role of virtual colonoscopy following incomplete optical colonoscopy: our experience 39
Impact of erlotinib on overall survival in non small cell lung cancer patients: is the post progression survival a new paradigm? 39
MYELODYSPLASTIC SYNDROMES DEVELOPING DURING IMATINIB THERAPY FOR GIST 38
TUMORS OF THE AMPULLA DIAGNOSED BY CT HYPOTONIC DUODENOGRAPHY 37
Re-treatment with gefitinib or treatment with erlotinib after gefitinib failure in responsive non small cell lung cancers: new strategies to overcome acquired resistance. 23
Totale 2.215
Categoria #
all - tutte 6.799
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.799


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201911 0 0 0 0 0 0 0 0 0 0 3 8
2019/2020314 44 20 3 14 2 47 42 32 6 34 56 14
2020/2021323 37 8 61 22 17 30 12 19 7 43 49 18
2021/2022275 3 43 4 8 11 3 15 5 4 72 36 71
2022/2023737 53 79 33 71 68 80 4 36 281 4 15 13
2023/2024179 20 15 12 14 9 83 18 2 1 5 0 0
Totale 2.215